A new development in malaria:
“Plasmodium vivax, the world’s most common malara parasite, now infects people previously considered to be resistant.”
Peter Zimmerman from Case Western Reserve University school of medicine spoke at the AAAS meeting in Washington on February 19th.
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
“So, red blood cells of most African people do not express the Duffy blood-group protein. Now, the Duffy blood-group protein is essentially necessary for Plasmodium vivax to get into the red cell. Duffy-negative Africans have been considered to be resistant to Plasmodium vivax.”
Zimmerman studied Malagasy populations on Madagascar. He found that 10 percent of Duffy-negative subjects were in fact infected with Plasmodium vivax.
“So we’ve shown that Plasmodium vivax has cleared Duffy negativity. If Plasmodium vivax is evolving to learn how to infect the Duffy-negative red cell, then a large continent of people suddenly becomes susceptible to a new form of malaria.”
—Steve Mirsky
[The above text is an exact transcript of this podcast.]
Subscribe to Support Independent Journalism
Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.
When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.
Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber
